University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 15 of 18
Trigeminal Nerve Stimulation for Depression: Dose Finding
NCT01343563
Safety Interaction Trial Ibudilast and Methamphetamine
NCT01217970
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation
NCT02123108
Safety of Body Composition Analysis in Heart Failure Patients With Implantable Cardioverter Defibrillators (ICDs)
NCT01568606
Stroke Inpatient Rehabilitation Reinforcement of ACTivity
NCT01246882
Trigeminal Nerve Stimulation for Post Traumatic Stress Disorder (PTSD) and Depression
NCT01335217
Preventing Drug Use in Low Income Clinic Populations
NCT01942876
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918
Milnacipran for Treatment of Pain in Older Adults With Rheumatoid Arthritis
NCT01225991
A Positron Emission Tomography (PET) Study Evaluating Brain Metabolism of a Medical Food in Alzheimer's Disease
NCT01122329
Vitamin D in HIV-Infected Patients on HAART
NCT01250899
Promotora-based Latino Family CVD Risk Reduction
NCT01714271
Starting Treatment With Agonist Replacement Therapies Follow-up Study
NCT01592461
Drum-Assisted Therapy for Native Americans
NCT01356667
Effects of Vitamin D Insufficiency in Man
NCT01848236
Wear Characteristics of Denture Teeth
NCT01188226
Exercise as a Strategy to Treat Cognitive Dysfunction in Persons With Multiple Sclerosis
NCT01219647
Pain, Opioids and Pro-Inflammatory Immune Responses
NCT01210066
Exhaled Carbon Monoxide (eCO) for Diffusing Capacity (DLCO) Correction
NCT01126047
HIV and Fat Accumulation
NCT01088295
Endothelin Blockade in Patients With Single Ventricle Physiology
NCT00989911
A Study to Compare the Effects of Different Sized Particles on Cells in the Nose
NCT01257191
Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)
NCT01185977
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage
NCT01158508
Mindfulness Based Relapse Prevention for Stimulant Users
NCT01094223
Evaluating an Emergency Department Observation Syncope Protocol for Older Adults
NCT01003262
Meditation to Reduce Caregiver Stress
NCT01537679
Exercise to Improve Outcomes of Treatment for Methamphetamine Users
NCT01103531
Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV
NCT00949234
UCLA-Amity Parolee Health Promotion Study
NCT01844414
Iyengar Yoga for Young People With Irritable Bowel Syndrome
NCT01107977
UCLA Tai Chi in a Community Setting Study
NCT01203657
Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis
NCT01907282
Curcumin in Rheumatoid Arthritis
NCT00752154
Intervention to Enable Stroke Survivors in Los Angeles County Hospitals to "Stay Within the Guidelines"
NCT00861081
Vitamin D Supplementation as Non-toxic Immunomodulation in Children With Crohn's Disease
NCT01046773
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
NCT01118988
Interventions for Communication in Autism Network
NCT01018407
Benefits of Walnuts for Male Reproductive Health
NCT01505140
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
NCT01011829
Biomarkers for Outcomes In Late-life Depression (BOLD)
NCT01082237
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease
NCT00999037
Pilot Trial of Bupropion Versus Placebo for Methamphetamine Abuse in Adolescents
NCT00994448
Safety Assessment of Atomoxetine With MA IV Administration
NCT01019707
Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques
NCT00992108
Management of Diabetes With Metformin In Patients With Chronic Heart Failure
NCT01122316
Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)
NCT00352599
Healthy Lifestyle Behavior Intervention for Latino Women
NCT01333241
A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease
NCT00969332
Broccoli Sprout Extract Effects on Allergic Inflammation in the Nose
NCT00882115
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.